Underwriting Precision Promote epigenetic testing as a way for insurers to verify smoking and alcohol use during underwriting, reducing self-report risk and claim surprises. Target mid-market and specialty insurers; offer pilot programs with measurable ROI on risk segmentation and pricing accuracy.

Workforce Screening Offer employer clients a confidential, quick turnaround tool for pre-employment screening and ongoing wellness programs, helping reduce fraud risk in benefits, guide cessation initiatives, and improve health metrics without major HR disruption.

Legal Evidence Position as objective data for lawsuits involving addiction, employer liability, or health claims; provide ready-to-use reports and expert engagement, with compliance-focused data handling and eDiscovery-ready outputs.

R&D Partnerships Engage researchers and pharma tech firms with an easy-to-integrate diagnostic platform to study addiction, relapse, and cessation product efficacy; highlight data flexibility and study-ready results.

Market Growth Align with the rising adoption of epigenetic-based risk tools in healthcare and insurance; propose channel partnerships (labs, healthcare providers, risk consultants) and pricing models suitable for small teams to accelerate broader adoption.